www.fdanews.com/articles/120055-pozen-earns-10-million-milestone-payment-from-astrazeneca

Pozen Earns $10 Million Milestone Payment From AstraZeneca

August 31, 2009

Chapel Hill-based drug company Pozen Inc. has earned a $10 million milestone payment in its ongoing development of an arthritis treatment called Vimovo.
Triangle Business Journal